Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial
- Conditions
- First Posted Date
- 2006-07-20
- Last Posted Date
- 2020-04-02
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 497
- Registration Number
- NCT00354302
- Locations
- ๐จ๐ฆ
Cambridge Memorial Hospital, Cambridge, Ontario, Canada
๐จ๐ฆOdette Cancer Centre, Toronto, Ontario, Canada
๐จ๐ฆSt. Michael's Hospital, Toronto, Ontario, Canada
BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer
- Conditions
- Interventions
- First Posted Date
- 2006-07-14
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 41
- Registration Number
- NCT00352079
- Locations
- ๐จ๐ฆ
Clinical Research Unit at Vancouver Coastal, Vancouver, British Columbia, Canada
๐จ๐ฆCHUQ-Pavillon Hotel-Dieu de Quebec, Quebec City, Quebec, Canada
๐จ๐ฆCentre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, Canada
Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
- Conditions
- Interventions
- First Posted Date
- 2006-06-29
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 80
- Registration Number
- NCT00346320
- Locations
- ๐จ๐ฆ
Tom Baker Cancer Centre, Calgary, Alberta, Canada
๐จ๐ฆBCCA - Fraser Valley Cancer Centre, Surrey, British Columbia, Canada
๐จ๐ฆBCCA - Vancouver Island Cancer Centre, Victoria, British Columbia, Canada
AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer
- Conditions
- First Posted Date
- 2006-06-23
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 31
- Registration Number
- NCT00343408
- Locations
- ๐จ๐ฆ
Ottawa Hospital Regional Cancer Centre - General Campus, Ottawa, Ontario, Canada
๐จ๐ฆPrincess Margaret Hospital, Toronto, Ontario, Canada
๐จ๐ฆJewish General Hospital - Montreal, Montreal, Quebec, Canada
Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma
- Conditions
- First Posted Date
- 2006-03-22
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 51
- Registration Number
- NCT00305812
- Locations
- ๐จ๐ฆ
Allan Blair Cancer Centre at Pasqua Hospital, Regina, Saskatchewan, Canada
๐จ๐ฆNova Scotia Cancer Centre, Halifax, Nova Scotia, Canada
๐จ๐ฆHopital Notre-Dame du CHUM, Montreal, Quebec, Canada
AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
- Conditions
- Interventions
- First Posted Date
- 2005-12-15
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 34
- Registration Number
- NCT00265876
- Locations
- ๐จ๐ฆ
Univ. Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada
๐จ๐ฆOttawa Health Research Institute - General Division, Ottawa, Ontario, Canada
๐จ๐ฆAlgoma District Cancer Program, Sault Ste. Marie, Ontario, Canada
Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
- Conditions
- Interventions
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 82
- Registration Number
- NCT00258388
- Locations
- ๐จ๐ฆ
London Regional Cancer Program, London, Canada
๐จ๐ฆBCCA - Cancer Centre for the Southern Interior, Kelowna, Canada
๐บ๐ธUniversity of Washington, Seattle, Washington, United States
OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer
- Conditions
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 15
- Registration Number
- NCT00258375
- Locations
- ๐จ๐ฆ
British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna, British Columbia, Canada
๐จ๐ฆBritish Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
๐จ๐ฆBCCA - Fraser Valley Cancer Centre, Surrey, British Columbia, Canada
Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer
- First Posted Date
- 2005-11-21
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 49
- Registration Number
- NCT00255788
- Locations
- ๐จ๐ฆ
Toronto Sunnybrook Regional Cancer Centre at Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada
๐จ๐ฆMargaret and Charles Juravinski Cancer Centre, Hamilton, Ontario, Canada
๐จ๐ฆBritish Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2005-10-27
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 296
- Registration Number
- NCT00245154
- Locations
- ๐จ๐ฆ
University Institute of Cardiology and, Quebec, Canada
๐ท๐ดOncological Institute "Ion Chiricuta", Cluj-Napoca, Romania
๐ท๐ดClinical County Hospital of Sibiu, Sibiu, Romania